Treatment by Lenalidomide in lower risk
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion—The GFM experience
✍
Fabien Le Bras; Marie Sebert; Charikleia Kelaidi; Thierry Lamy; François Dreyfus
📂
Article
📅
2011
🏛
Elsevier Science
🌐
English
⚖ 197 KB